Characterization and functional role of androgen-dependent PDE5 activity in the bladder.
暂无分享,去创建一个
M. Carini | G. Vannelli | G. Forti | M. Marini | L. Vignozzi | A. Morelli | S. Filippi | M. Gacci | M. Maggi | R. Mancina | B. Fibbi | P. Sandner
[1] C. Crescioli,et al. BXL‐628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder , 2007, The Prostate.
[2] C. Stief,et al. Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future. , 2006, European urology.
[3] J. Mulhall,et al. Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction. , 2006, The journal of sexual medicine.
[4] C. Crescioli,et al. Pre-clinical evidence and clinical translation of benign prostatic hyperplasia treatment by the vitamin D receptor agonist BXL-628 (Elocalcitol) , 2006, Journal of endocrinological investigation.
[5] L. Vignozzi,et al. Physiology of Erectile Function: An Update on Intracellular Molecular Processes , 2006 .
[6] K. McVary,et al. 920: Sildenafil Improves Erectile Function and Concomitant Lower Urinary Tract Symptoms in Men , 2006 .
[7] M. Giorgi,et al. Subcellular localization and regulation of type-1C and type-5 phosphodiesterases. , 2006, Biochemical and biophysical research communications.
[8] P. Hedlund. Nitric oxide/cGMP-mediated effects in the outflow region of the lower urinary tract—is there a basis for pharmacological targeting of cGMP? , 2005, World Journal of Urology.
[9] G. Vannelli,et al. Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum. , 2005, European urology.
[10] F. Montorsi,et al. Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens. , 2005, Molecular human reproduction.
[11] C. Crescioli,et al. Human bladder as a novel target for vitamin D receptor ligands. , 2005, The Journal of clinical endocrinology and metabolism.
[12] A. Wein,et al. Pharmacology of the Lower Urinary Tract: Basis for Current and Future Treatments of Urinary Incontinence , 2004, Pharmacological Reviews.
[13] Jerome P. Reiter,et al. EFFECTS OF α1-ADRENERGIC RECEPTOR SUBTYPE SELECTIVE ANTAGONISTS ON LOWER URINARY TRACT FUNCTION IN RATS WITH BLADDER OUTLET OBSTRUCTION , 2004 .
[14] A. Arner,et al. Urinary bladder contraction and relaxation: physiology and pathophysiology. , 2004, Physiological reviews.
[15] M. Giorgi,et al. Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. , 2004, Endocrinology.
[16] M. Serio,et al. Inhibition of spontaneous and androgen-induced prostate growth by a nonhypercalcemic calcitriol analog. , 2003, Endocrinology.
[17] V. Boddi,et al. Urinary symptoms, quality of life and sexual function in patients with benign prostatic hypertrophy before and after prostatectomy: a prospective study , 2003, BJU international.
[18] E. Kulinskaya,et al. Sildenafil influences lower urinary tract symptoms , 2002, BJU international.
[19] J. de Vente,et al. Activity and expression of nitric oxide synthase in the hypertrophied rat bladder and the effect of nitric oxide on bladder smooth muscle growth. , 2002, The Journal of urology.
[20] M. Giorgi,et al. Type 5 phosphodiesterase expression in the human vagina. , 2002, Urology.
[21] Xiulin Liu,et al. Identification and functional study of phosphodiesterases in rat urinary bladder , 2001, Urological Research.
[22] S. Black,et al. sGC and PDE5 are elevated in lambs with increased pulmonary blood flow and pulmonary hypertension. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[23] R. Morgan,et al. Nitric oxide in the lower urinary tract: physiological and pathological implications , 2000, BJU international.
[24] J. Keast. The autonomic nerve supply of male sex organs – an important target of circulating androgens , 1999, Behavioural Brain Research.
[25] K. Fujishige,et al. Cloning and Characterization of a Novel Human Phosphodiesterase That Hydrolyzes Both cAMP and cGMP (PDE10A)* , 1999, The Journal of Biological Chemistry.
[26] J. Beavo,et al. Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. Beavo,et al. Identification and Characterization of a Novel Family of Cyclic Nucleotide Phosphodiesterases* , 1998, The Journal of Biological Chemistry.
[28] S. Phillips,et al. Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5). , 1998, Biochemical and biophysical research communications.
[29] S. Snyder,et al. Urinary bladder-urethral sphincter dysfunction in mice with targeted disruption of neuronal nitric oxide synthase models idiopathic voiding disorders in humans , 1997, Nature Medicine.
[30] D. Bredt,et al. Vesicourethral function in mice with genetic disruption of neuronal nitric oxide synthase. , 1997, The Journal of urology.
[31] R. Theobald. The effect of NG-monomethyl-L-arginine on bladder function. , 1996, European journal of pharmacology.
[32] K. Andersson,et al. Nitric oxide synthase in pig lower urinary tract: immunohistochemistry, NADPH diaphorase histochemistry and functional effects , 1993, British journal of pharmacology.
[33] S. Hill,et al. Partial mediation by nitric oxide of the relaxation of human isolated detrusor strips in response to electrical field stimulation. , 1993, British journal of clinical pharmacology.
[34] K. Andersson,et al. Nitric oxide and relaxation of pig lower urinary tract , 1992, British journal of pharmacology.
[35] D. Rodbard,et al. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. , 1978, The American journal of physiology.
[36] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[37] G. Prins,et al. Location and concentration of estrogen, progesterone, and androgen receptors in the bladder and urethra of the rabbit , 1995, Neurourology and urodynamics.
[38] T. Morita,et al. Regional difference in functional roles of cAMP and cGMP in lower urinary tract smooth muscle contractility. , 1992, Urologia internationalis.